The DOI matches its Crossref record; 263 of the 263 references it cites were found in a registry or an index.
Cytokines as Therapeutic Targets in Rheumatoid Arthritis and Other Inflammatory Diseases
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Evaluation of Diagnostic Criteria for Ankylosing Spondylitis
Linden, S. V. D., Valkenburg, H. A., & Cats, A. (1984) · Arthritis & Rheumatism · doi:10.1002/art.1780270401 · Cited by 5,697
Maintenance infliximab for Crohn's disease: the ACCENT I randomised trial
Hanauer, S. B., Feagan, B. G., Lichtenstein, G. R., Mayer, L. F., Schreiber, S., Colombel, J. F., Rachmilewitz, D., Wolf, D. C., Olson, A., Bao, W., et al. (2002) · The Lancet · doi:10.1016/s0140-6736(02)08512-4 · Cited by 4,169
Infliximab for Induction and Maintenance Therapy for Ulcerative Colitis
Rutgeerts, P., Sandborn, W. J., Feagan, B. G., Reinisch, W., Olson, A., Johanns, J., Travers, S., Rachmilewitz, D., Hanauer, S. B., Lichtenstein, G. R., et al. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa050516 · Cited by 3,902
Tuberculosis Associated with Infliximab, a Tumor Necrosis Factor α–Neutralizing Agent
Keane, J., Gershon, S., Wise, R. P., Mirabile-Levens, E., Kasznica, J., Schwieterman, W. D., Siegel, J. N., & Braun, M. M. (2001) · New England Journal of Medicine · doi:10.1056/nejmoa011110 · Cited by 3,710
Rudwaleit, M., van der Heijde, D., Landewé, R., Listing, J., Akkoc, N., Brandt, J., Braun, J., Chou, C. T., Collantes-Estevez, E., Dougados, M., et al. (2009) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2009.108233 · Cited by 3,690
Infliximab, Azathioprine, or Combination Therapy for Crohn's Disease
Colombel, J. F., Sandborn, W. J., Reinisch, W., Mantzaris, G. J., Kornbluth, A., Rachmilewitz, D., Lichtiger, S., D'Haens, G., Diamond, R. H., Broussard, D. L., et al. (2010) · New England Journal of Medicine · doi:10.1056/nejmoa0904492 · Cited by 3,143
Targan, S. R., Hanauer, S. B., van Deventer, S. J. H., Mayer, L., Present, D. H., Braakman, T., DeWoody, K. L., Schaible, T. F., & Rutgeerts, P. J. (1997) · New England Journal of Medicine · doi:10.1056/nejm199710093371502 · Cited by 3,135
American college of rheumatology preliminary definition of improvement in rheumatoid arthritis
Felson, D. T., Anderson, J. J., Boers, M., Bombardier, C., Furst, D., Goldsmith, C., Katz, L. M., Lightfoot, R., Paulus, H., Strand, V., et al. (1995) · Arthritis & Rheumatism · doi:10.1002/art.1780380602 · Cited by 2,829
Bongartz, T., Sutton, A. J., Sweeting, M. J., Buchan, I., Matteson, E. L., & Montori, V. (2006) · JAMA · doi:10.1001/jama.295.19.2275 · Cited by 2,468
Maini, R., St Clair, E. W., Breedveld, F., Furst, D., Kalden, J., Weisman, M., Smolen, J., Emery, P., Harriman, G., Feldmann, M., et al. (1999) · The Lancet · doi:10.1016/s0140-6736(99)05246-0 · Cited by 2,345
Colombel, J., Sandborn, W. J., Rutgeerts, P., Enns, R., Hanauer, S. B., Panaccione, R., Schreiber, S., Byczkowski, D., Li, J., Kent, J. D., et al. (2007) · Gastroenterology · doi:10.1053/j.gastro.2006.11.041 · Cited by 2,245
Infliximab Maintenance Therapy for Fistulizing Crohn's Disease
Sands, B. E., Anderson, F. H., Bernstein, C. N., Chey, W. Y., Feagan, B. G., Fedorak, R. N., Kamm, M. A., Korzenik, J. R., Lashner, B. A., Onken, J. E., et al. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa030815 · Cited by 2,226
Smolen, J. S., Landewé, R., Bijlsma, J., Burmester, G., Chatzidionysiou, K., Dougados, M., Nam, J., Ramiro, S., Voshaar, M., van Vollenhoven, R., et al. (2017) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2016-210715 · Cited by 2,057
Self-citationInfluence of Immunogenicity on the Long-Term Efficacy of Infliximab in Crohn's Disease
Baert, F., Noman, M., Vermeire, S., Van Assche, G., D' Haens, G., Carbonez, A., & Rutgeerts, P. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa020888 · Cited by 2,015
Leonardi, C. L., Kimball, A. B., Papp, K. A., Yeilding, N., Guzzo, C., Wang, Y., Li, S., Dooley, L. T., & Gordon, K. B. (2008) · The Lancet · doi:10.1016/s0140-6736(08)60725-4 · Cited by 1,874
Breedveld, F. C., Weisman, M. H., Kavanaugh, A. F., Cohen, S. B., Pavelka, K., Vollenhoven, R. V., Sharp, J., Perez, J. L., & Spencer‐Green, G. T. (2006) · Arthritis & Rheumatism · doi:10.1002/art.21519 · Cited by 1,785
Smolen, J. S., Landewé, R., Breedveld, F. C., Buch, M., Burmester, G., Dougados, M., Emery, P., Gaujoux-Viala, C., Gossec, L., Nam, J., et al. (2014) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2013-204573 · Cited by 1,763
Weinblatt, M. E., Keystone, E. C., Furst, D. E., Moreland, L. W., Weisman, M. H., Birbara, C. A., Teoh, L. A., Fischkoff, S. A., & Chartash, E. K. (2003) · Arthritis & Rheumatism · doi:10.1002/art.10697 · Cited by 1,757
Klareskog, L., van der Heijde, D., de Jager, J. P., Gough, A., Kalden, J., Malaise, M., Mola, E. M., Pavelka, K., Sany, J., Settas, L., et al. (2004) · The Lancet · doi:10.1016/s0140-6736(04)15640-7 · Cited by 1,751
Hanauer, S. B., Sandborn, W. J., Rutgeerts, P., Fedorak, R. N., Lukas, M., MacIntosh, D., Panaccione, R., Wolf, D., & Pollack, P. (2006) · Gastroenterology · doi:10.1053/j.gastro.2005.11.030 · Cited by 1,715
Osborn, L., Hession, C., Tizard, R., Vassallo, C., Luhowskyj, S., Chi-Rosso, G., & Lobb, R. (1989) · Cell · doi:10.1016/0092-8674(89)90775-7 · Cited by 1,689
Felson, D. T., Anderson, J. J., Boers, M., Bombardier, C., Chernoff, M., Fried, B., Furst, D., Goldsmith, C., Kieszak, S., Lightfoot, R., et al. (1993) · Arthritis & Rheumatism · doi:10.1002/art.1780360601 · Cited by 1,640
Tumor necrosis factor antagonist mechanisms of action: A comprehensive review
Tracey, D., Klareskog, L., Sasso, E. H., Salfeld, J. G., & Tak, P. P. (2008) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2007.10.001 · Cited by 1,628
Hueber, W., Sands, B. E., Lewitzky, S., Vandemeulebroecke, M., Reinisch, W., Higgins, P. D. R., Wehkamp, J., Feagan, B. G., Yao, M. D., Karczewski, M., et al. (2012) · Gut · doi:10.1136/gutjnl-2011-301668 · Cited by 1,547
Targeting IL-17 and TH17 cells in chronic inflammation
Miossec, P., & Kolls, J. K. (2012) · Nature Reviews Drug Discovery · doi:10.1038/nrd3794 · Cited by 1,414
Pober, J. S., Gimbrone, M. A., Lapierre, L. A., Mendrick, D. L., Fiers, W., Rothlein, R., & Springer, T. A. (1986) · The Journal of Immunology · doi:10.4049/jimmunol.137.6.1893 · Cited by 1,413
Smolen, J. S., Beaulieu, A., Rubbert-Roth, A., Ramos-Remus, C., Rovensky, J., Alecock, E., Woodworth, T., & Alten, R. (2008) · The Lancet · doi:10.1016/s0140-6736(08)60453-5 · Cited by 1,399
Etanercept Therapy in Rheumatoid Arthritis: A Randomized, Controlled Trial
Moreland, L. W., Schiff, M. H., Baumgartner, S. W., Tindall, E. A., Fleischmann, R. M., Bulpitt, K. J., Weaver, A. L., Keystone, E. C., Furst, D. E., Mease, P. J., et al. (1999) · Annals of Internal Medicine · doi:10.7326/0003-4819-130-6-199903160-00004 · Cited by 1,379
Papp, K. A., Langley, R. G., Lebwohl, M., Krueger, G. G., Szapary, P., Yeilding, N., Guzzo, C., Hsu, M.-C., Wang, Y., Li, S., et al. (2008) · The Lancet · doi:10.1016/s0140-6736(08)60726-6 · Cited by 1,361
Sandborn, W. J., van Assche, G., Reinisch, W., Colombel, J., D’Haens, G., Wolf, D. C., Kron, M., Tighe, M. B., Lazar, A., & Thakkar, R. B. (2012) · Gastroenterology · doi:10.1053/j.gastro.2011.10.032 · Cited by 1,269
Braun, J., Brandt, J., Listing, J., Zink, A., Alten, R., Golder, W., Gromnica-lhle, E., Kellner, H., Krause, A., Schneider, M., et al. (2002) · The Lancet · doi:10.1016/s0140-6736(02)08215-6 · Cited by 1,261
Casadevall, N., Nataf, J., Viron, B., Kolta, A., Kiladjian, J.-J., Martin-Dupont, P., Michaud, P., Papo, T., Ugo, V., Teyssandier, I., et al. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa011931 · Cited by 1,246
Doran, M. F., Crowson, C. S., Pond, G. R., O'Fallon, W. M., & Gabriel, S. E. (2002) · Arthritis & Rheumatism · doi:10.1002/art.10524 · Cited by 1,214
Etanercept as Monotherapy in Patients with Psoriasis
Leonardi, C. L., Powers, J. L., Matheson, R. T., Goffe, B. S., Zitnik, R., Wang, A., & Gottlieb, A. B. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa030409 · Cited by 1,175
TACI and BCMA are receptors for a TNF homologue implicated in B-cell autoimmune disease
Gross, J. A., Johnston, J., Mudri, S., Enselman, R., Dillon, S. R., Madden, K., Xu, W., Parrish-Novak, J., Foster, D., Lofton-Day, C., et al. (2000) · Nature · doi:10.1038/35010115 · Cited by 1,174
Certolizumab Pegol for the Treatment of Crohn's Disease
Sandborn, W. J., Feagan, B. G., Stoinov, S., Honiball, P. J., Rutgeerts, P., Mason, D., Bloomfield, R., & Schreiber, S. (2007) · New England Journal of Medicine · doi:10.1056/nejmoa067594 · Cited by 1,143
Ustekinumab Induction and Maintenance Therapy in Refractory Crohn's Disease
Sandborn, W. J., Gasink, C., Gao, L.-L., Blank, M. A., Johanns, J., Guzzo, C., Sands, B. E., Hanauer, S. B., Targan, S., Rutgeerts, P., et al. (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1203572 · Cited by 1,134
BRENNAN, F. (1989) · The Lancet · doi:10.1016/s0140-6736(89)90430-3 · Cited by 1,129
Emery, P., Keystone, E., Tony, H. P., Cantagrel, A., van Vollenhoven, R., Sanchez, A., Alecock, E., Lee, J., & Kremer, J. (2008) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2008.092932 · Cited by 1,104
Tyring, S., Gottlieb, A., Papp, K., Gordon, K., Leonardi, C., Wang, A., Lalla, D., Woolley, M., Jahreis, A., Zitnik, R., et al. (2006) · The Lancet · doi:10.1016/s0140-6736(05)67763-x · Cited by 1,069 · cited 1×
“A second randomized controlled trial compared a higher dose of etanercept (50 mg twice weekly) with placebo in 618 patients with moderateto-severe psoriasis (Tyring et al., 2006).”
BackgroundChronic Mucocutaneous Candidiasis in Humans with Inborn Errors of Interleukin-17 Immunity
Puel, A., Cypowyj, S., Bustamante, J., Wright, J. F., Liu, L., Lim, H. K., Migaud, M., Israel, L., Chrabieh, M., Audry, M., et al. (2011) · Science · doi:10.1126/science.1200439 · Cited by 1,056 · cited 1×
“Individuals with genetic deficiencies in IL-17A and IL-17F are prone to chronic mucocutaneous candidiasis and possibly Staphylococcus aureus (Puel et al., 2011).”
BackgroundMaintenance Therapy with Certolizumab Pegol for Crohn's Disease
Schreiber, S., Khaliq-Kareemi, M., Lawrance, I. C., Thomsen, O. Ø., Hanauer, S. B., McColm, J., Bloomfield, R., & Sandborn, W. J. (2007) · New England Journal of Medicine · doi:10.1056/nejmoa062897 · Cited by 1,043
Treatment of rheumatoid arthritis with chimeric monoclonal antibodies to tumor necrosis factor α
Elliott, M. J., Maini, R. N., Feldmann, M., Long‐Fox, A., Charles, P., Katsikis, P., Brennan, F. M., Walker, J., Bijl, H., Ghrayeb, J., et al. (1993) · Arthritis & Rheumatism · doi:10.1002/art.1780361206 · Cited by 1,038
Anti-tumor necrosis factor ameliorates joint disease in murine collagen-induced arthritis.
Williams, R. O., Feldmann, M., & Maini, R. N. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.20.9784 · Cited by 989
Treatment of rheumatoid arthritis with recombinant human interleukin-1 receptor antagonist
Bresnihan, B., Alvaro-Gracia, J. M., Cobby, M., Doherty, M., Domljan, Z., Emery, P., Nuki, G., Pavelka, K., Rau, R., Rozman, B., et al. (1998) · Arthritis & Rheumatism · doi:10.1002/1529-0131(199812)41:12<2196::aid-art15>3.0.co;2-2 · Cited by 981
Granulomatous Infectious Diseases Associated with Tumor Necrosis Factor Antagonists
Wallis, R. S., Broder, M. S., Wong, J. Y., Hanson, M. E., & Beenhouwer, D. O. (2004) · Clinical Infectious Diseases · doi:10.1086/383317 · Cited by 977
Brodalumab, an Anti–Interleukin-17–Receptor Antibody for Psoriasis
Papp, K. A., Leonardi, C., Menter, A., Ortonne, J.-P., Krueger, J. G., Kricorian, G., Aras, G., Li, J., Russell, C. B., Thompson, E. H. Z., et al. (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1109017 · Cited by 941
Sandborn, W. J., Feagan, B. G., Marano, C., Zhang, H., Strauss, R., Johanns, J., Adedokun, O. J., Guzzo, C., Colombel, J.-F., Reinisch, W., et al. (2014) · Gastroenterology · doi:10.1053/j.gastro.2013.05.048 · Cited by 940
Anti–Interleukin-17 Monoclonal Antibody Ixekizumab in Chronic Plaque Psoriasis
Leonardi, C., Matheson, R., Zachariae, C., Cameron, G., Li, L., Edson-Heredia, E., Braun, D., & Banerjee, S. (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1109997 · Cited by 936
Etanercept for active Crohn's disease: A randomized, double-blind, placebo-controlled trial
Sandborn, W. J., Hanauer, S. B., Katz, S., Safdi, M., Wolf, D. G., Baerg, R. D., Tremaine, W. J., Johnson, T., Diehl, N. N., & Zinsmeister, A. R. (2001) · Gastroenterology · doi:10.1053/gast.2001.28674 · Cited by 910
Mease, P. J., Gladman, D. D., Ritchlin, C. T., Ruderman, E. M., Steinfeld, S. D., Choy, E. H. S., Sharp, J. T., Ory, P. A., Perdok, R. J., & Weinberg, M. A. (2005) · Arthritis & Rheumatism · doi:10.1002/art.21306 · Cited by 909
Reinisch, W., Sandborn, W. J., Hommes, D. W., D'Haens, G., Hanauer, S., Schreiber, S., Panaccione, R., Fedorak, R. N., Tighe, M. B., Huang, B., et al. (2011) · Gut · doi:10.1136/gut.2010.221127 · Cited by 892
Adalimumab therapy for moderate to severe psoriasis: A randomized, controlled phase III trial
Menter, A., Tyring, S. K., Gordon, K., Kimball, A. B., Leonardi, C. L., Langley, R. G., Strober, B. E., Kaul, M., Gu, Y., Okun, M., et al. (2008) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2007.09.010 · Cited by 889
Etanercept treatment of psoriatic arthritis: Safety, efficacy, and effect on disease progression
Mease, P. J., Kivitz, A. J., Burch, F. X., Siegel, E. L., Cohen, S. B., Ory, P., Salonen, D., Rubenstein, J., Sharp, J. T., & Tsuji, W. (2004) · Arthritis & Rheumatism · doi:10.1002/art.20335 · Cited by 882
van der Heijde, D., Kivitz, A., Schiff, M. H., Sieper, J., Dijkmans, B. A. C., Braun, J., Dougados, M., Reveille, J. D., Wong, R. L., Kupper, H., et al. (2006) · Arthritis & Rheumatism · doi:10.1002/art.21913 · Cited by 872
van der Heijde, D., Dijkmans, B., Geusens, P., Sieper, J., DeWoody, K., Williamson, P., & Braun, J. (2005) · Arthritis & Rheumatism · doi:10.1002/art.20852 · Cited by 860
Hueber, W., Patel, D. D., Dryja, T., Wright, A. M., Koroleva, I., Bruin, G., Antoni, C., Draelos, Z., Gold, M. H., the Psoriasis Study Group, et al. (2010) · Science Translational Medicine · doi:10.1126/scitranslmed.3001107 · Cited by 860
Comparison of Ustekinumab and Etanercept for Moderate-to-Severe Psoriasis
Griffiths, C. E. M., Strober, B. E., van de Kerkhof, P., Ho, V., Fidelus-Gort, R., Yeilding, N., Guzzo, C., Xia, Y., Zhou, B., Li, S., et al. (2010) · New England Journal of Medicine · doi:10.1056/nejmoa0810652 · Cited by 859
Genovese, M. C., McKay, J. D., Nasonov, E. L., Mysler, E. F., da Silva, N. A., Alecock, E., Woodworth, T., & Gomez‐Reino, J. J. (2008) · Arthritis & Rheumatism · doi:10.1002/art.23940 · Cited by 855
A Human Interleukin-12/23 Monoclonal Antibody for the Treatment of Psoriasis
Krueger, G. G., Langley, R. G., Leonardi, C., Yeilding, N., Guzzo, C., Wang, Y., Dooley, L. T., & Lebwohl, M. (2007) · New England Journal of Medicine · doi:10.1056/nejmoa062382 · Cited by 807
McInnes, I. B., Kavanaugh, A., Gottlieb, A. B., Puig, L., Rahman, P., Ritchlin, C., Brodmerkel, C., Li, S., Wang, Y., Mendelsohn, A. M., et al. (2013) · The Lancet · doi:10.1016/s0140-6736(13)60594-2 · Cited by 807
Self-citationCheema, G. S., Roschke, V., Hilbert, D. M., & Stohl, W. (2001) · Arthritis & Rheumatism · doi:10.1002/1529-0131(200106)44:6<1313::aid-art223>3.0.co;2-s · Cited by 802
Jones, G., Sebba, A., Gu, J., Lowenstein, M. B., Calvo, A., Gomez-Reino, J. J., Siri, D. A., Tomšič, M., Alecock, E., Woodworth, T., et al. (2010) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2008.105197 · Cited by 797
Maini, R. N., Taylor, P. C., Szechinski, J., Pavelka, K., Bröll, J., Balint, G., Emery, P., Raemen, F., Petersen, J., Smolen, J., et al. (2006) · Arthritis & Rheumatism · doi:10.1002/art.22033 · Cited by 790
Bartelds, G. M. (2011) · JAMA · doi:10.1001/jama.2011.406 · Cited by 782
Randomized trial of tocilizumab in systemic juvenile idiopathic arthritis
De Benedetti, F., Brunner, H. I., Ruperto, N., Kenwright, A., Wright, S., Calvo, I., Cuttica, R., Ravelli, A., Schneider, R., Woo, P., et al. (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1112802 · Cited by 763
Davis, J. C., Van Der Heijde, D., Braun, J., Dougados, M., Cush, J., Clegg, D. O., Kivitz, A., Fleischmann, R., Inman, R., Tsuji, W., et al. (2003) · Arthritis & Rheumatism · doi:10.1002/art.11325 · Cited by 754
Humanized anti–interleukin-6 receptor antibody treatment of multicentric Castleman disease
Nishimoto, N., Kanakura, Y., Aozasa, K., Johkoh, T., Nakamura, M., Nakano, S., Nakano, N., Ikeda, Y., Sasaki, T., Nishioka, K., et al. (2005) · Blood · doi:10.1182/blood-2004-12-4602 · Cited by 754
Sandborn, W. J., Feagan, B. G., Fedorak, R. N., Scherl, E., Fleisher, M. R., Katz, S., Johanns, J., Blank, M., & Rutgeerts, P. (2008) · Gastroenterology · doi:10.1053/j.gastro.2008.07.014 · Cited by 753
Dixon, W. G., Watson, K., Lunt, M., Hyrich, K. L., Silman, A. J., & Symmons, D. P. M. (2006) · Arthritis & Rheumatism · doi:10.1002/art.21978 · Cited by 751
Tumour necrosis factor α stimulates resorption and inhibits synthesis of proteoglycan in cartilage
Saklatvala, J. (1986) · Nature · doi:10.1038/322547a0 · Cited by 745
D'Haens, G., Van Deventer, S., Van Hogezand, R., Chalmers, D., Kothe, C., Baert, F., Braakman, T., Schaible, T., Geboes, K., & Rutgeerts, P. (1999) · Gastroenterology · doi:10.1016/s0016-5085(99)70005-3 · Cited by 745
Saurat, J. ‐., Stingl, G., Dubertret, L., Papp, K. A., Langley, R. G. B., Ortonne, J. ‐., Unnebrink, K., Kaul, M., Camez, A., & for the CHAMPION Study Investigators (2007) · British Journal of Dermatology · doi:10.1111/j.1365-2133.2007.08315.x · Cited by 728
Sandborn, W. J., Feagan, B. G., Marano, C., Zhang, H., Strauss, R., Johanns, J., Adedokun, O. J., Guzzo, C., Colombel, J., Reinisch, W., et al. (2014) · Gastroenterology · doi:10.1053/j.gastro.2013.06.010 · Cited by 727
Nishimoto, N., Hashimoto, J., Miyasaka, N., Yamamoto, K., Kawai, S., Takeuchi, T., Murata, N., van der Heijde, D., & Kishimoto, T. (2007) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2006.068064 · Cited by 727
Van den Brande, J. M. H., Braat, H., van den Brink, G. R., Versteeg, H. H., Bauer, C. A., Hoedemaeker, I., van Montfrans, C., Hommes, D. W., Peppelenbosch, M. P., & van Deventer, S. J. H. (2003) · Gastroenterology · doi:10.1016/s0016-5085(03)00382-2 · Cited by 723
Dixon, W. G., Hyrich, K. L., Watson, K. D., Lunt, M., Galloway, J., Ustianowski, A., & Symmons, D. P. M. (2010) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2009.118935 · Cited by 715
Infliximab improves signs and symptoms of psoriatic arthritis: results of the IMPACT 2 trial
Antoni, C., Krueger, G. G., de Vlam, K., Birbara, C., Beutler, A., Guzzo, C., Zhou, B., Dooley, L. T., & Kavanaugh, A. (2005) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2004.032268 · Cited by 715
Infliximab Therapy in Patients with Chronic Sarcoidosis and Pulmonary Involvement
Baughman, R. P., Drent, M., Kavuru, M., Judson, M. A., Costabel, U., du Bois, R., Albera, C., Brutsche, M., Davis, G., Donohue, J. F., et al. (2006) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200603-402oc · Cited by 714
Ramiro, S., Gaujoux-Viala, C., Nam, J. L., Smolen, J. S., Buch, M., Gossec, L., van der Heijde, D., Winthrop, K., & Landewé, R. (2014) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2013-204575 · Cited by 701
Braun, J., Bollow, M., Neure, L., Seipelt, E., Seyrekbasan, F., Herbst, H., Eggens, U., Distler, A., & Sieper, J. (1995) · Arthritis & Rheumatism · doi:10.1002/art.1780380407 · Cited by 690
Galloway, J. B., Hyrich, K. L., Mercer, L. K., Dixon, W. G., Fu, B., Ustianowski, A. P., Watson, K. D., Lunt, M., BSRBR Control Centre Consortium, Symmons, D. P. M., et al. (2011) · Rheumatology · doi:10.1093/rheumatology/keq242 · Cited by 676
Gabay, C., Emery, P., van Vollenhoven, R., Dikranian, A., Alten, R., Pavelka, K., Klearman, M., Musselman, D., Agarwal, S., Green, J., et al. (2013) · The Lancet · doi:10.1016/s0140-6736(13)60250-0 · Cited by 672
Targeting interleukin-6 in inflammatory autoimmune diseases and cancers
Yao, X., Huang, J., Zhong, H., Shen, N., Faggioni, R., Fung, M., & Yao, Y. (2014) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2013.09.004 · Cited by 664
Ritchlin, C., Rahman, P., Kavanaugh, A., McInnes, I. B., Puig, L., Li, S., Wang, Y., Shen, Y.-K., Doyle, M. K., Mendelsohn, A. M., et al. (2014) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2013-204655 · Cited by 662
Self-citationYoo, D. H., Hrycaj, P., Miranda, P., Ramiterre, E., Piotrowski, M., Shevchuk, S., Kovalenko, V., Prodanovic, N., Abello-Banfi, M., Gutierrez-Ureña, S., et al. (2013) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2012-203090 · Cited by 654
Antoni, C. E., Kavanaugh, A., Kirkham, B., Tutuncu, Z., Burmester, G. R., Schneider, U., Furst, D. E., Molitor, J., Keystone, E., Gladman, D., et al. (2005) · Arthritis & Rheumatism · doi:10.1002/art.20967 · Cited by 640
Cohen, S., Hurd, E., Cush, J., Schiff, M., Weinblatt, M. E., Moreland, L. W., Kremer, J., Bear, M. B., Rich, W. J., & McCabe, D. (2002) · Arthritis & Rheumatism · doi:10.1002/art.10141 · Cited by 638
Tubach, F., Salmon, D., Ravaud, P., Allanore, Y., Goupille, P., Bréban, M., Pallot‐Prades, B., Pouplin, S., Sacchi, A., Chichemanian, R. M., et al. (2009) · Arthritis & Rheumatism · doi:10.1002/art.24632 · Cited by 632
Adalimumab with or without Methotrexate in Juvenile Rheumatoid Arthritis
Lovell, D. J., Ruperto, N., Goodman, S., Reiff, A., Jung, L., Jarosova, K., Nemcova, D., Mouy, R., Sandborg, C., Bohnsack, J., et al. (2008) · New England Journal of Medicine · doi:10.1056/nejmoa0706290 · Cited by 625
Dayer, J. M., de Rochemonteix, B., Burrus, B., Demczuk, S., & Dinarello, C. A. (1986) · Journal of Clinical Investigation · doi:10.1172/jci112350 · Cited by 624
Hyrich, K. L., Watson, K. D., Silman, A. J., Symmons, D. P. M., & Register, T. B. B. (2006) · Rheumatology · doi:10.1093/rheumatology/kel149 · Cited by 623
GM-CSF Regulates Alveolar Macrophage Differentiation and Innate Immunity in the Lung through PU.1
Shibata, Y., Berclaz, P.-Y., Chroneos, Z. C., Yoshida, M., Whitsett, J. A., & Trapnell, B. C. (2001) · Immunity · doi:10.1016/s1074-7613(01)00218-7 · Cited by 618
Bean, A. G. D., Roach, D. R., Briscoe, H., France, M. P., Korner, H., Sedgwick, J. D., & Britton, W. J. (1999) · The Journal of Immunology · doi:10.4049/jimmunol.162.6.3504 · Cited by 618
Anderson, J. J., Baron, G., Van Der Heijde, D., Felson, D. T., & Dougados, M. (2001) · Arthritis & Rheumatism · doi:10.1002/1529-0131(200108)44:8<1876::aid-art326>3.0.co;2-f · Cited by 606
Park, W., Hrycaj, P., Jeka, S., Kovalenko, V., Lysenko, G., Miranda, P., Mikazane, H., Gutierrez-Ureña, S., Lim, M., Lee, Y.-A., et al. (2013) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2012-203091 · Cited by 606
Kavanaugh, A., McInnes, I., Mease, P., Krueger, G. G., Gladman, D., Gomez‐Reino, J., Papp, K., Zrubek, J., Mudivarthy, S., Mack, M., et al. (2009) · Arthritis & Rheumatism · doi:10.1002/art.24403 · Cited by 602
Self-citationEpidemiology of psoriatic arthritis in the population of the United States
Gelfand, J. M., Gladman, D. D., Mease, P. J., Smith, N., Margolis, D. J., Nijsten, T., Stern, R. S., Feldman, S. R., & Rolstad, T. (2005) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2005.03.046 · Cited by 596
Baeten, D., Baraliakos, X., Braun, J., Sieper, J., Emery, P., van der Heijde, D., McInnes, I., van Laar, J. M., Landewé, R., Wordsworth, P., et al. (2013) · The Lancet · doi:10.1016/s0140-6736(13)61134-4 · Cited by 595
Self-citationInman, R. D., Davis, J. C., Heijde, D. V. D., Diekman, L., Sieper, J., Kim, S. I., Mack, M., Han, J., Visvanathan, S., Xu, Z., et al. (2008) · Arthritis & Rheumatism · doi:10.1002/art.23969 · Cited by 593
Gottlieb, A., Menter, A., Mendelsohn, A., Shen, Y.-K., Li, S., Guzzo, C., Fretzin, S., Kunynetz, R., & Kavanaugh, A. (2009) · The Lancet · doi:10.1016/s0140-6736(09)60140-9 · Cited by 585
Incidence of Cancer Among Patients With Rheumatoid Arthritis
Gridley, G., McLaughlin, J. K., Ekbom, A., Klareskog, L., Adami, H.-O., Hacker, D. G., Hoover, R., & Fraumeni, J. F. (1993) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/85.4.307 · Cited by 581
Keystone, E., Heijde, D. V. D., Mason, D., Landewé, R., Vollenhoven, R. V., Combe, B., Emery, P., Strand, V., Mease, P., Desai, C., et al. (2008) · Arthritis & Rheumatism · doi:10.1002/art.23964 · Cited by 576
Shi, Y., Liu, C. H., Roberts, A. I., Das, J., Xu, G., Ren, G., Zhang, Y., Zhang, L., Yuan, Z. R., Tan, H. S. W., et al. (2006) · Cell Research · doi:10.1038/sj.cr.7310017 · Cited by 547
Risk of Herpes Zoster in Patients With Rheumatoid Arthritis Treated With Anti–TNF-α Agents
Strangfeld, A. (2009) · JAMA · doi:10.1001/jama.2009.146 · Cited by 542
Keystone, E. C., Genovese, M. C., Klareskog, L., Hsia, E. C., Hall, S. T., Miranda, P. C., Pazdur, J., Bae, S.-C., Palmer, W., Zrubek, J., et al. (2009) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2008.099010 · Cited by 541
Hetland, M. L., Christensen, I. J., Tarp, U., Dreyer, L., Hansen, A., Hansen, I. T., Kollerup, G., Linde, L., Lindegaard, H., Poulsen, U. E., et al. (2009) · Arthritis & Rheumatism · doi:10.1002/art.27227 · Cited by 538
Sieper, J., van der Heijde, D., Dougados, M., Mease, P. J., Maksymowych, W. P., Brown, M. A., Arora, V., & Pangan, A. L. (2013) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2012-201766 · Cited by 536
Wolfe, F., & Michaud, K. (2007) · Arthritis & Rheumatism · doi:10.1002/art.22864 · Cited by 534
Chevalier, X., Goupille, P., Beaulieu, A. D., Burch, F. X., Bensen, W. G., Conrozier, T., Loeuille, D., Kivitz, A. J., Silver, D., & Appleton, B. E. (2009) · Arthritis Care & Research · doi:10.1002/art.24096 · Cited by 533
Genovese, M. C., Cohen, S., Moreland, L., Lium, D., Robbins, S., Newmark, R., Bekker, P., & for the 20000223 Study Group (2004) · Arthritis & Rheumatism · doi:10.1002/art.20221 · Cited by 532
Synovial membrane inflammation and cytokine production in patients with early osteoarthritis.
Smith, M., Triantafillou, S., Parker, A., Youssef, P. P., & Coleman, M. (1997) · PubMed · Cited by 525
Murch, S. H., Braegger, C. P., Walker-Smith, J. A., & MacDonald, T. T. (1993) · Gut · doi:10.1136/gut.34.12.1705 · Cited by 520
Menter, A., Feldman, S. R., Weinstein, G. D., Papp, K., Evans, R., Guzzo, C., Li, S., Dooley, L. T., Arnold, C., & Gottlieb, A. B. (2007) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2006.07.017 · Cited by 516
MACDONALD, T. T., HUTCHINGS, P., CHOY, M.-Y., MURCH, S., & COOKE, A. (2008) · Clinical and Experimental Immunology · doi:10.1111/j.1365-2249.1990.tb03334.x · Cited by 478
Nesbitt, A., Fossati, G., Bergin, M., Stephens, P., Stephens, S., Foulkes, R., Brown, D., Robinson, M., & Bourne, T. (2007) · Inflammatory Bowel Diseases · doi:10.1002/ibd.20225 · Cited by 477
Acceptable changes in quality attributes of glycosylated biopharmaceuticals
Schiestl, M., Stangler, T., Torella, C., Čepeljnik, T., Toll, H., & Grau, R. (2011) · Nature Biotechnology · doi:10.1038/nbt.1839 · Cited by 473
Landewé, R., Braun, J., Deodhar, A. A., Dougados, M., Maksymowych, W. P., Mease, P. J., Reveille, J. D., Rudwaleit, M., van der Heijde, D. M. F. M., Stach, C. M., et al. (2013) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2013-204231 · Cited by 470
Inborn errors of IL-12/23- and IFN-γ-mediated immunity: molecular, cellular, and clinical features
Filipe-Santos, O., Bustamante, J., Chapgier, A., Vogt, G., de Beaucoudrey, L., Feinberg, J., Jouanguy, E., Boisson-Dupuis, S., Fieschi, C., Picard, C., et al. (2006) · Seminars in Immunology · doi:10.1016/j.smim.2006.07.010 · Cited by 464
van Rhee, F., Wong, R. S., Munshi, N., Rossi, J.-F., Ke, X.-Y., Fosså, A., Simpson, D., Capra, M., Liu, T., Hsieh, R. K., et al. (2014) · The Lancet Oncology · doi:10.1016/s1470-2045(14)70319-5 · Cited by 454
Papp, K. A., Griffiths, C. E. M., Gordon, K., Lebwohl, M., Szapary, P. O., Wasfi, Y., Chan, D., Hsu, M.-C., Ho, V., Ghislain, P. D., et al. (2013) · British Journal of Dermatology · doi:10.1111/bjd.12214 · Cited by 415
Garcês, S., Demengeot, J., & Benito-Garcia, E. (2013) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2012-202220 · Cited by 411
Kremer, J. M., Blanco, R., Brzosko, M., Burgos-Vargas, R., Halland, A.-M., Vernon, E., Ambs, P., & Fleischmann, R. (2011) · Arthritis & Rheumatism · doi:10.1002/art.30158 · Cited by 409
Nam, J. L., Winthrop, K. L., van Vollenhoven, R. F., Pavelka, K., Valesini, G., Hensor, E. M. A., Worthy, G., Landewé, R., Smolen, J. S., Emery, P., et al. (2010) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2009.126573 · Cited by 406
Chen, Y.-F., Jobanputra, P., Barton, P., Jowett, S., Bryan, S., Clark, W., Fry-Smith, A., & Burls, A. (2006) · Health Technology Assessment · doi:10.3310/hta10420 · Cited by 406
Mariette, X., Matucci-Cerinic, M., Pavelka, K., Taylor, P., van Vollenhoven, R., Heatley, R., Walsh, C., Lawson, R., Reynolds, A., & Emery, P. (2011) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2010.149419 · Cited by 404
Hyrich, K. L., Lunt, M., Watson, K. D., Symmons, D. P. M., Silman, A. J., & British Society for Rheumatology Biologics Register (2007) · Arthritis & Rheumatism · doi:10.1002/art.22331 · Cited by 401
Brodalumab, an Anti-IL17RA Monoclonal Antibody, in Psoriatic Arthritis
Mease, P. J., Genovese, M. C., Greenwald, M. W., Ritchlin, C. T., Beaulieu, A. D., Deodhar, A., Newmark, R., Feng, J., Erondu, N., & Nirula, A. (2014) · New England Journal of Medicine · doi:10.1056/nejmoa1315231 · Cited by 395
Fleischmann, R. M., Schechtman, J., Bennett, R., Handel, M. L., Burmester, G., Tesser, J., Modafferi, D., Poulakos, J., & Sun, G. (2003) · Arthritis & Rheumatism · doi:10.1002/art.10870 · Cited by 392
Etanercept for the Treatment of Stage II and III Progressive Pulmonary Sarcoidosis
Utz, J. P., Limper, A. H., Kalra, S., Specks, U., Scott, J. P., Vuk-Pavlovic, Z., & Schroeder, D. R. (2003) · Chest · doi:10.1378/chest.124.1.177 · Cited by 390
TNFα—A PIVOTAL ROLE IN RHEUMATOID ARTHRITIS?
BRENNAN, F. M., MAINI, R. N., & FELDMANN, M. (1992) · Rheumatology · doi:10.1093/rheumatology/31.5.293 · Cited by 386
Integrated safety in tocilizumab clinical trials
Schiff, M. H., Kremer, J. M., Jahreis, A., Vernon, E., Isaacs, J. D., & van Vollenhoven, R. F. (2011) · Arthritis Research & Therapy · doi:10.1186/ar3455 · Cited by 367
Leombruno, J. P., Einarson, T. R., & Keystone, E. C. (2009) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2008.091025 · Cited by 362
Papp, K. A., Langley, R. G., Sigurgeirsson, B., Abe, M., Baker, D. R., Konno, P., Haemmerle, S., Thurston, H. J., Papavassilis, C., & Richards, H. B. (2013) · British Journal of Dermatology · doi:10.1111/bjd.12110 · Cited by 360
Nam, J. L., Ramiro, S., Gaujoux-Viala, C., Takase, K., Leon-Garcia, M., Emery, P., Gossec, L., Landewe, R., Smolen, J. S., & Buch, M. H. (2014) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2013-204577 · Cited by 354
Van den Bosch, F., Kruithof, E., Baeten, D., Herssens, A., de Keyser, F., Mielants, H., & Veys, E. M. (2002) · Arthritis & Rheumatism · doi:10.1002/art.511 · Cited by 352
Grijalva, C. G., Chen, L., Delzell, E., Baddley, J. W., Beukelman, T., Winthrop, K. L., Griffin, M. R., Herrinton, L. J., Liu, L., Ouellet-Hellstrom, R., et al. (2011) · JAMA · doi:10.1001/jama.2011.1692 · Cited by 350
McInnes, I. B., Sieper, J., Braun, J., Emery, P., van der Heijde, D., Isaacs, J. D., Dahmen, G., Wollenhaupt, J., Schulze-Koops, H., Kogan, J., et al. (2014) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2012-202646 · Cited by 343
Self-citationNishimoto, N., Miyasaka, N., Yamamoto, K., Kawai, S., Takeuchi, T., & Azuma, J. (2009) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2008.092866 · Cited by 337
An APRIL to remember: novel TNF ligands as therapeutic targets
Dillon, S. R., Gross, J. A., Ansell, S. M., & Novak, A. J. (2006) · Nature Reviews Drug Discovery · doi:10.1038/nrd1982 · Cited by 321
Brunner, H. I., Ruperto, N., Zuber, Z., Keane, C., Harari, O., Kenwright, A., Lu, P., Cuttica, R., Keltsev, V., Xavier, R. M., et al. (2015) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2014-205351 · Cited by 316
The Effect of Synovial Tissue on the Breakdown of Articular Cartilage in Organ Culture
Fell, H. B., & Jubb, R. W. (1977) · Arthritis & Rheumatism · doi:10.1002/art.1780200710 · Cited by 310
Cohen, S. B., Moreland, L. W., Cush, J. J., Greenwald, M. W., Block, S., Shergy, W. J., Hanrahan, P. S., Kraishi, M. M., Patel, A., Sun, G., et al. (2004) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2003.016014 · Cited by 305
Partsch, G., Steiner, G. E., Leeb, B. F., Dunky, A., Bröll, H., & Smolen, J. S. (1997) · PubMed · Cited by 297
Rudwaleit, M., Rødevand, E., Holck, P., Vanhoof, J., Kron, M., Kary, S., & Kupper, H. (2009) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2008.092585 · Cited by 297
Kavanaugh, A., Ritchlin, C., Rahman, P., Puig, L., Gottlieb, A. B., Li, S., Wang, Y., Noonan, L., Brodmerkel, C., Song, M., et al. (2014) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2013-204741 · Cited by 295
Self-citationGenovese, M. C., Durez, P., Richards, H. B., Supronik, J., Dokoupilova, E., Mazurov, V., Aelion, J. A., Lee, S.-H., Codding, C. E., Kellner, H., et al. (2013) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2012-201601 · Cited by 293
Gomez-Reino, J. J., Carmona, L., & the BIOBADASER Group (2006) · Arthritis Research & Therapy · doi:10.1186/ar1881 · Cited by 289
Dougados, M., Kissel, K., Sheeran, T., Tak, P. P., Conaghan, P. G., Mola, E. M., Schett, G., Amital, H., Navarro-Sarabia, F., Hou, A., et al. (2013) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2011-201282 · Cited by 287
Malottki, K., Barton, P., Tsourapas, A., Uthman, A., Liu, Z., Routh, K., Connock, M., Jobanputra, P., Moore, D., Fry-Smith, A., et al. (2011) · Health Technology Assessment · doi:10.3310/hta15140 · Cited by 287
Scott Algood, H. M., Lin, P. L., & Flynn, J. L. (2005) · Clinical Infectious Diseases · doi:10.1086/429994 · Cited by 278
Greenberg, J. D., Reed, G., Kremer, J. M., Tindall, E., Kavanaugh, A., Zheng, C., Bishai, W., & Hochberg, M. C. (2010) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2008.089276 · Cited by 275
Mitoma, H., Horiuchi, T., Hatta, N., Tsukamoto, H., Harashima, S.-I., Kikuchi, Y., Otsuka, J., Okamura, S., Fujita, S., & Harada, M. (2005) · Gastroenterology · doi:10.1053/j.gastro.2004.11.060 · Cited by 270
Changes in lipid levels with inflammation and therapy in RA: a maturing paradigm
Robertson, J., Peters, M. J., McInnes, I. B., & Sattar, N. (2013) · Nature Reviews Rheumatology · doi:10.1038/nrrheum.2013.91 · Cited by 264
Self-citationStrangfeld, A., Hierse, F., Rau, R., Burmester, G.-R., Krummel-Lorenz, B., Demary, W., Listing, J., & Zink, A. (2010) · Arthritis Research & Therapy · doi:10.1186/ar2904 · Cited by 264
Poddubnyy, D., Hermann, K.-G. A., Callhoff, J., Listing, J., & Sieper, J. (2014) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2013-204248 · Cited by 260
Xu, W. D., Firestein, G. S., Taetle, R., Kaushansky, K., & Zvaifler, N. J. (1989) · Journal of Clinical Investigation · doi:10.1172/jci113971 · Cited by 258
Pascual-Salcedo, D., Plasencia, C., Ramiro, S., Nuno, L., Bonilla, G., Nagore, D., Ruiz del Agua, A., Martinez, A., Aarden, L., Martin-Mola, E., et al. (2011) · Rheumatology · doi:10.1093/rheumatology/ker124 · Cited by 256
Th17 and Th22 cells in psoriatic arthritis and psoriasis
Benham, H., Norris, P., Goodall, J., Wechalekar, M. D., FitzGerald, O., Szentpetery, A., Smith, M., Thomas, R., & Gaston, H. (2013) · Arthritis Research & Therapy · doi:10.1186/ar4317 · Cited by 253
British Society for Rheumatology Biologics Register
Silman, A. J., Symmons, D. P. M., Scott, D. G. I., & Griffiths, I. (2003) · Annals of the Rheumatic Diseases · doi:10.1136/ard.62.suppl_2.ii28 · Cited by 248
Rich, P., Sigurgeirsson, B., Thaçi, D., Ortonne, J. ‐., Paul, C. F., Schopf, R. E., Morita, A., Roseau, K., Harfst, E., Guettner, A., et al. (2013) · British Journal of Dermatology · doi:10.1111/bjd.12112 · Cited by 244
Burmester, G. R., Rubbert-Roth, A., Cantagrel, A., Hall, S., Leszczynski, P., Feldman, D., Rangaraj, M. J., Roane, G., Ludivico, C., Lu, P., et al. (2014) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2013-203523 · Cited by 243
Furst, D. E., Wallis, R., Broder, M., & Beenhouwer, D. O. (2006) · Seminars in Arthritis and Rheumatism · doi:10.1016/j.semarthrit.2006.02.001 · Cited by 233
Bartelds, G. M., Wijbrandts, C. A., Nurmohamed, M. T., Stapel, S., Lems, W. F., Aarden, L., Dijkmans, B. A. C., Tak, P. P., & Wolbink, G. J. (2010) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2009.112847 · Cited by 225
Winthrop, K. L., Baddley, J. W., Chen, L., Liu, L., Grijalva, C. G., Delzell, E., Beukelman, T., Patkar, N. M., Xie, F., Saag, K. G., et al. (2013) · JAMA · doi:10.1001/jama.2013.1099 · Cited by 223
Huizinga, T. W. J., Fleischmann, R. M., Jasson, M., Radin, A. R., van Adelsberg, J., Fiore, S., Huang, X., Yancopoulos, G. D., Stahl, N., & Genovese, M. C. (2014) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2013-204405 · Cited by 222
Soliman, M. M., Ashcroft, D. M., Watson, K. D., Lunt, M., Symmons, D. P. M., & Hyrich, K. L. (2011) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2010.139774 · Cited by 218
Deleuran, B. W., Chu, C., Field, M., Brennan, F. M., Mitchell, T., Feldmann, M., & Maini, R. N. (1992) · Arthritis & Rheumatism · doi:10.1002/art.1780351009 · Cited by 217
Raaschou, P., Simard, J. F., Holmqvist, M., Askling, J., & for the ARTIS Study Group (2013) · BMJ · doi:10.1136/bmj.f1939 · Cited by 213
Genovese, M. C., Greenwald, M., Cho, C., Berman, A., Jin, L., Cameron, G. S., Benichou, O., Xie, L., Braun, D., Berclaz, P., et al. (2014) · Arthritis & Rheumatology · doi:10.1002/art.38617 · Cited by 211
Tak, P. P., Thurlings, R. M., Rossier, C., Nestorov, I., Dimic, A., Mircetic, V., Rischmueller, M., Nasonov, E., Shmidt, E., Emery, P., et al. (2008) · Arthritis & Rheumatism · doi:10.1002/art.23178 · Cited by 207
Galloway, J. B., Hyrich, K. L., Mercer, L. K., Dixon, W. G., Ustianowski, A. P., Helbert, M., Watson, K. D., Lunt, M., & Symmons, D. P. M. (2011) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2011.152769 · Cited by 205
Kurzrock, R., Voorhees, P. M., Casper, C., Furman, R. R., Fayad, L., Lonial, S., Borghaei, H., Jagannath, S., Sokol, L., Usmani, S. Z., et al. (2013) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-12-3349 · Cited by 205
Verbruggen, G., Wittoek, R., Cruyssen, B. V., & Elewaut, D. (2012) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2011.149849 · Cited by 202
Nelson, E., O'Meara, S., Craig, D., Iglesias, C., Golder, S., Dalton, J., Claxton, K., Bell-Syer, S., Jude, E., Dowson, C., et al. (2006) · Health Technology Assessment · doi:10.3310/hta10120 · Cited by 201
Immunogenicity and autoimmunity during anti-TNF therapy
Atzeni, F., Talotta, R., Salaffi, F., Cassinotti, A., Varisco, V., Battellino, M., Ardizzone, S., Pace, F., & Sarzi-Puttini, P. (2013) · Autoimmunity Reviews · doi:10.1016/j.autrev.2012.10.021 · Cited by 196
Koike, T., Harigai, M., Inokuma, S., Ishiguro, N., Ryu, J., Takeuchi, T., Takei, S., Tanaka, Y., Ito, K., & Yamanaka, H. (2011) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2011.151092 · Cited by 194
Rich, P., Sigurgeirsson, B., Thaci, D. P., Ortonne, J.-P., Paul, C., Schopf, R. E., Morita, A., Roseau, K., Harfst, E., Guettner, A., et al. (2012) · British Journal of Dermatology · doi:10.1111/bjd.12070 · Cited by 189
Cook, A. D., Braine, E. L., Campbell, I. K., Rich, M. J., & Hamilton, J. A. (2001) · Arthritis Research & Therapy · doi:10.1186/ar318 · Cited by 186
Chevalier, X., Ravaud, P., Maheu, E., Baron, G., Rialland, A., Vergnaud, P., Roux, C., Maugars, Y., Mulleman, D., Lukas, C., et al. (2015) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2014-205348 · Cited by 180
Anakinra for rheumatoid arthritis
Mertens, M., & Singh, J. A. (2009) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd005121.pub3 · Cited by 179
Jamnitski, A., Bartelds, G. M., Nurmohamed, M. T., van Schouwenburg, P. A., van Schaardenburg, D., Stapel, S. O., Dijkmans, B. A. C., Aarden, L., & Wolbink, G. J. (2011) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2010.135111 · Cited by 178
Landewé, R., van der Heijde, D., Klareskog, L., van Vollenhoven, R., & Fatenejad, S. (2006) · Arthritis & Rheumatism · doi:10.1002/art.22143 · Cited by 177
Galloway, J. B., Mercer, L. K., Moseley, A., Dixon, W. G., Ustianowski, A. P., Helbert, M., Watson, K. D., Lunt, M., Hyrich, K. L., & Symmons, D. P. (2013) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2011-201108 · Cited by 174
Furst, D. E. (2004) · Clinical Therapeutics · doi:10.1016/j.clinthera.2004.12.019 · Cited by 171
Finckh, A., Ciurea, A., Brulhart, L., Möller, B., Walker, U. A., Courvoisier, D., Kyburz, D., Dudler, J., & Gabay, C. (2010) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2008.105064 · Cited by 169
van Vollenhoven, R. F., Kinnman, N., Vincent, E., Wax, S., & Bathon, J. (2011) · Arthritis & Rheumatism · doi:10.1002/art.30372 · Cited by 167
Spector, T. D. (1990) · Rheumatic Disease Clinics of North America · doi:10.1016/s0889-857x(21)00886-3 · Cited by 165
Burmester, G. R., Feist, E., Kellner, H., Braun, J., Iking-Konert, C., & Rubbert-Roth, A. (2011) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2010.139725 · Cited by 164
Cui, J., Stahl, E. A., Saevarsdottir, S., Miceli, C., Diogo, D., Trynka, G., Raj, T., Mirkov, M. U., Canhao, H., Ikari, K., et al. (2013) · PLoS Genetics · doi:10.1371/journal.pgen.1003394 · Cited by 164
Efficacy and safety of mavrilimumab in subjects with rheumatoid arthritis
Burmester, G. R., Weinblatt, M. E., McInnes, I. B., Porter, D. R., Барбараш, О. Л., Vatutin, M. T., Szombati, I., Esfandiari, E., Sleeman, M. A., Kane, C. D., et al. (2012) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2012-202450 · Cited by 161
Self-citationKristensen, L. E., Kapetanovic, M. C., Gulfe, A., Soderlin, M., Saxne, T., & Geborek, P. (2007) · Rheumatology · doi:10.1093/rheumatology/ken002 · Cited by 160
Reich, K., Ortonne, J.-P., Gottlieb, A. B., Terpstra, I. J., Coteur, G., Tasset, C., & Mease, P. (2012) · British Journal of Dermatology · doi:10.1111/j.1365-2133.2012.10941.x · Cited by 158
Antoni, C., Kavanaugh, A., van der Heijde, D. M. F. M., et al. (2008) · PubMed · Cited by 156
Pharmacology of TNF blockade in rheumatoid arthritis and other chronic inflammatory diseases
Taylor, P. C. (2010) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2010.01.005 · Cited by 155
Emery, P., Gottenberg, J., Rubbert‐Roth, A., Sarzi‐Puttini, P., Choquette, D., Taboada, V. M. M., Barile-Fabris, L. A., Moots, R. J., Östör, A. J. K., Andrianakos, A., et al. (2014) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2013-203993 · Cited by 155
Yazıcı, Y., Curtis, J. R., Ince, A., Baraf, H. S. B., Malamet, R., Teng, L. L., & Kavanaugh, A. (2011) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2010.148700 · Cited by 155
Alten, R., Gómez-Reino, J. J., Durez, P., Beaulieu, A. D., Sebba, A. I., Krammer, G., Preiss, R., Arulmani, U., Widmer, A., Gitton, X., et al. (2011) · BMC Musculoskeletal Disorders · doi:10.1186/1471-2474-12-153 · Cited by 154
Glintborg, B., Østergaard, M., Krogh, N. S., Tarp, U., Manilo, N., Loft, A. G., Hansen, A., Schlemmer, A., Fana, V., Lindegaard, H., et al. (2012) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2012-201933 · Cited by 149
Mercer, L., Davies, R., Galloway, J. B., Low, A., Lunt, M., Dixon, W. G., Watson, K. D., Symmons, D. P. M., & Hyrich, K. L. (2012) · Rheumatology · doi:10.1093/rheumatology/kes350 · Cited by 145
Cited by
Phosphodiesterase-4 Inhibitors for the Treatment of Inflammatory Diseases
Li, H., Zuo, J., & Tang, W. (2018) · Frontiers in Pharmacology · doi:10.3389/fphar.2018.01048 · Cited by 580
Flavonoids as Cytokine Modulators: A Possible Therapy for Inflammation-Related Diseases
Leyva-López, N., Gutierrez-Grijalva, E., Ambriz-Perez, D., & Heredia, J. (2016) · International Journal of Molecular Sciences · doi:10.3390/ijms17060921 · Cited by 337
The effect of exercise on cytokines: implications for musculoskeletal health: a narrative review
Docherty, S., Harley, R., McAuley, J. J., Crowe, L. A. N., Pedret, C., Kirwan, P. D., Siebert, S., & Millar, N. L. (2022) · BMC Sports Science, Medicine and Rehabilitation · doi:10.1186/s13102-022-00397-2 · Cited by 292
Self-citationBispecific antibodies and their applications
Fan, G., Wang, Z., Hao, M., & Li, J. (2015) · Journal of Hematology & Oncology · doi:10.1186/s13045-015-0227-0 · Cited by 288
NLRP3 inflammasome activation contributes to the pathogenesis of rheumatoid arthritis
Guo, C., Fu, R., Wang, S., Huang, Y., Li, X., Zhou, M., Zhao, J., & Yang, N. (2018) · Clinical and Experimental Immunology · doi:10.1111/cei.13167 · Cited by 285
Metadata
- Authors
- Siebert, S., Tsoukas, A., Robertson, J., & McInnes, I.
- Venue
- Pharmacological Reviews
- Publisher
- Elsevier BV
- Published
- 2015-04
- Volume
- 67
- Issue
- 2
- Pages
- 280-309
- ISSN
- 0031-6997 (ISSN-L)
- OpenAlex
- W2135510881
- Cited by
- 307
- References
- 263
- FWCI
- 31.84
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.